DE69020240D1 - Verfahren zur Herstellung von Beta-lactamase-Inhibitoren. - Google Patents

Verfahren zur Herstellung von Beta-lactamase-Inhibitoren.

Info

Publication number
DE69020240D1
DE69020240D1 DE69020240T DE69020240T DE69020240D1 DE 69020240 D1 DE69020240 D1 DE 69020240D1 DE 69020240 T DE69020240 T DE 69020240T DE 69020240 T DE69020240 T DE 69020240T DE 69020240 D1 DE69020240 D1 DE 69020240D1
Authority
DE
Germany
Prior art keywords
beta
preparation
solution
lactamase inhibitors
methoxyphenol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69020240T
Other languages
English (en)
Other versions
DE69020240T2 (de
Inventor
Raghavan Krishnan
Jesse Gamble
David Blum
William V Curran
Ving J Lee
Ransom B Conrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE69020240D1 publication Critical patent/DE69020240D1/de
Application granted granted Critical
Publication of DE69020240T2 publication Critical patent/DE69020240T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69020240T 1989-05-12 1990-04-02 Verfahren zur Herstellung von Beta-lactamase-Inhibitoren. Expired - Lifetime DE69020240T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,966 US4958020A (en) 1989-05-12 1989-05-12 Process for producing β-lactamase inhibitor

Publications (2)

Publication Number Publication Date
DE69020240D1 true DE69020240D1 (de) 1995-07-27
DE69020240T2 DE69020240T2 (de) 1996-04-04

Family

ID=23378993

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69020240T Expired - Lifetime DE69020240T2 (de) 1989-05-12 1990-04-02 Verfahren zur Herstellung von Beta-lactamase-Inhibitoren.

Country Status (10)

Country Link
US (1) US4958020A (de)
EP (1) EP0396901B1 (de)
JP (1) JP2909145B2 (de)
KR (1) KR0144453B1 (de)
AT (1) ATE124048T1 (de)
CA (1) CA2016500C (de)
DE (1) DE69020240T2 (de)
DK (1) DK0396901T3 (de)
ES (1) ES2073471T3 (de)
HU (1) HU206724B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3306473B1 (ja) * 2001-05-01 2002-07-24 大塚化学株式会社 β−ラクタム化合物の無水結晶及びその製造法
US20060173177A1 (en) * 2005-01-28 2006-08-03 Gego Csaba L Process for preparation of penam derivatives
US20070286817A1 (en) * 2006-06-07 2007-12-13 Wyeth Treating cystic fibrosis with antibiotics via a swirler delivery
US20070286818A1 (en) * 2006-06-07 2007-12-13 Wyeth Treating cystic fibrosis with antibiotics via an aerosol drug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU541028B2 (en) * 1982-06-21 1984-12-13 Taiho Pharmaceutical Co., Ltd. 6-unsubstituted penicillin derivatives
JPS58225091A (ja) * 1982-06-21 1983-12-27 Taiho Yakuhin Kogyo Kk ペニシリン誘導体及びその製造法
US4562073A (en) * 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
US4496484A (en) * 1983-04-22 1985-01-29 Taiho Pharmaceutical Company, Limited Penicillin derivatives
CA1239392A (en) * 1983-10-13 1988-07-19 Shigeru Yamabe Penicillin derivatives and process for preparing the same
JPS61126087A (ja) * 1984-11-26 1986-06-13 Taiho Yakuhin Kogyo Kk ２α−メチル−２β−（１，２，３−トリアゾ−ル−１−イル）メチルペナム−３α−カルボン酸誘導体の製造法
JPS63112588A (ja) * 1986-10-27 1988-05-17 Denki Kagaku Kogyo Kk トリアゾ−ル誘導体の製造方法

Also Published As

Publication number Publication date
US4958020A (en) 1990-09-18
ATE124048T1 (de) 1995-07-15
JPH02311482A (ja) 1990-12-27
KR0144453B1 (ko) 1998-07-15
EP0396901B1 (de) 1995-06-21
CA2016500C (en) 2000-11-28
HUT54693A (en) 1991-03-28
ES2073471T3 (es) 1995-08-16
HU903007D0 (en) 1990-09-28
JP2909145B2 (ja) 1999-06-23
EP0396901A1 (de) 1990-11-14
HU206724B (en) 1992-12-28
DK0396901T3 (da) 1995-08-14
CA2016500A1 (en) 1990-11-12
DE69020240T2 (de) 1996-04-04
KR900018115A (ko) 1990-12-20

Similar Documents

Publication Publication Date Title
DE69126646D1 (de) Biologisches Verfahren zur Herstellung von optisch-aktiver Milchsäure
DE69020240D1 (de) Verfahren zur Herstellung von Beta-lactamase-Inhibitoren.
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
ATE66209T1 (de) Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ATE106887T1 (de) Ester der 10-(1-hydroxy-äthyl)-11-oxo-1- azatricyclo(7.2.0.0(3,8)>undec-2-ene-2- carbonsäure und deren derivate und verfahren zu ihrer herstellung.
DE59307005D1 (de) Verfahren zur Herstellung von Ph3C[B(C6F5)4]
ATE81491T1 (de) Plastifizierungsmittel, verfahren zu seiner herstellung sowie seine verwendung.
DE69032341T2 (de) Verfahren zur Herstellung von optisch aktiven Verbindungen mit mehrfachen chiralen Mittelpunkten
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
ATE128457T1 (de) Optisch aktive n-aplha-fluoracryloylaminosäure- derivate, ihre herstellung, die daraus hergestellten optisch aktiven polymeren und deren verwendung zur spaltung von racematen.
PT70592A (de) Neue 3,4-disubstituierte 2-phenylimino-imidazolidine derensaureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
DE69113323D1 (de) Verfahren zur Herstellung von alpha-Hydroxycarbonsäure amiden.
ATE31301T1 (de) Verfahren zur herstellung von 4-carbamoyl-1himidazolium-5-olat.
DE3864524D1 (de) Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten.
ATE215931T1 (de) Verfahren zur herstellung von 2- oxopyrrolidinylacetamid-derivaten
DE69131444T2 (de) Optisch aktive 1,4-Dihydropyridinderivate sowie Verfahren zu ihrer Herstellung
IT1197800B (it) Processo per la sintesi di acidi carbossilici
DE59402632D1 (de) Verfahren zur Herstellung von 3beta-Aminocholansäurederivaten
DE69619267T2 (de) Verfahren zur herstellung von 3-amino-1,2,4-benzotriazindioxide
DE59103279D1 (de) Verfahren zur Herstellung von optisch aktiven aliphatischen Hydroxycarbonsäureestern.
DE68908843T2 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
ATA214393A (de) Verfahren zur herstellung von 7-amino-3-cephem-4-carbonsäure-derivaten
DE3851942T2 (de) Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure.
ATE35676T1 (de) Verfahren zur herstellung von harnstoffacrylderivaten.
HU914124D0 (en) Process for producing optically active quinoxalinyl-oxi-phenoxi-propionic acid esthers

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US